Document Type

Article

Publication Date

10-18-2013

Keywords

Human Microbiome Project, HMP, biologics, regulation

Comments

This is the authors' version of the work. It is posted here by permission of the AAAS for personal use, not for redistribution. The definitive version was published in Science Policy Forum, vol. 342, October 18, 2013. see: http://www.sciencemag.org/content/342/6156/314.full?ijkey=QUF.p5J3snuso&keytype=ref&siteid=sci

DOI: 10.1126/science.1244656

Abstract

Some products marketed as drugs should be excused from Phase I trials, but safety and efficacy claims for dietary supplements should be more tightly regulated.

Publication Citation

342 Science 6156 (2013)

Disciplines

Food Biotechnology | Food Microbiology | Medical Biotechnology | Medical Microbiology

Download

Share

COinS